2020
DOI: 10.1186/s12879-020-05144-x
|View full text |Cite
|
Sign up to set email alerts
|

Risk factors for disease progression in COVID-19 patients

Abstract: Background: Coronavirus disease (COVID-19) is rapidly spreading worldwide. Although 10-20% of patients with COVID-19 have severe symptoms, little is known about the risk factors related to the aggravation of COVID-19 symptoms from asymptomatic or mild to severe disease states. Methods: This retrospective study included 211 patients who were asymptomatic or with mild presentations of COVID-19. We evaluated the differences in demographic and clinical data between the cured (discharged to home) and transferred (a… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

7
109
2
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 128 publications
(119 citation statements)
references
References 21 publications
7
109
2
1
Order By: Relevance
“…In the meta-analysis conducted by Hariyanto and Kurniawan, 38 7 observational studies were analyzed. 45 47 48 49 50 51 52 In each study, dyslipidemia or hyperlipidemia was defined according to patients' history based on electronic medical records regardless of additional laboratory testing or the use of lipid-lowering drugs. Four of the 7 studies were conducted in China, and 1 study each from the US, France, and Korea was included.…”
Section: Discussionmentioning
confidence: 99%
“…In the meta-analysis conducted by Hariyanto and Kurniawan, 38 7 observational studies were analyzed. 45 47 48 49 50 51 52 In each study, dyslipidemia or hyperlipidemia was defined according to patients' history based on electronic medical records regardless of additional laboratory testing or the use of lipid-lowering drugs. Four of the 7 studies were conducted in China, and 1 study each from the US, France, and Korea was included.…”
Section: Discussionmentioning
confidence: 99%
“…The symptoms of this highly contagious disease include dry cough, fever, anosmia (loss of smell), weakness, headache, body pains, vomiting, sore throat, and respiratory difficulty, and the onset of symptoms ranges from 1-14 days (Ahmed, 2020;Wang et al, 2020). Some infected individuals may remain asymptomatic (without symptoms) after contracting the virus (Daniel & Oran, 2020;Lee et al, 2020), whereas among the symptomatic cases, the majority of them are mild or moderate (Bi et al, 2020;Chang et al, 2020), with about 10% being severe (Bi et al, 2020;Chang et al, 2020).…”
Section: Introductionmentioning
confidence: 99%
“…Previous studies have roughly delineated several risk factors of poor progression of COVID-19, such as age, diabetes, neutrophil-to-lymphocyte ratio, obesity, and dyspnea [4][5][6][7][8]. Nevertheless, these studies usually investigated the association between a single risk factor and a subjective classi cation of cases, which is not suitable for an early risk assessment of multiple risk factors among an affected population.…”
Section: Introductionmentioning
confidence: 99%